Application of “Systems Vaccinology” to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative Vaccines

Figure 1

Integration of multiparametric “omics” data with clinical events from human clinical trials, together with population genetics, pediatric cohorts, and animal models in the BIOVACSAFE project.